NanoViricides, Inc. (NNVC.PK) Appoints Id3A, LLC as Architect for Its Previously Announced cGMP Production and Laboratory Facility
1/2/2013 9:23:48 AM
WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (OTC BB: NNVC) (the "Company") announced today that it has retained Id3A, LLC (“Id3A”), as the architect for its laboratory and cGMP pilot production facility project. As previously announced, this facility will be built by renovating an existing 18,000 sq. ft. light manufacturing plant on a 4.2 acre lot in Shelton, CT. Ms. Kathyann Cowles, AIA, will serve as the Principal Architect for the project. Id3A recently began working with the Company for the architecture portion and now the Company has formally engaged Id3A as the architects for this project. Id3A will be responsible for the overall facility architecture, including integration of a separately constructed Clean Room Suite for cGMP production. Ms Cowles will join Mr. Andrew Hahn and Mr. Phil Mader of MPH Engineering, LLC (MPH) to complete our architecture, design and construction management team. As previously announced, Mr. Hahn continues to provide overall stewardship of the project, while Mr. Mader is responsible for detailed project management, and his firm, MPH, is providing engineering services.
comments powered by